Edition 44 – Accessible Medical Education and TIC: Increasing Equitable Care for Disabled Patients
Accessible Medical Education and TIC: Increasing Equitable Care for Disabled Patients Christina Jean Su and Peppar EP Cyr Facebook Twitter LinkedIn Citation Su C, Cyr P. Accessible Medical Education and TIC: Increasing Equitable Care for Disabled Patients. HPHR. 2021;44. DOI:10.54111/0001/RR1 Disability and Public Health Abstract An estimated 1 in 4 U.S. adults has a disability, […]
Edition 36 – House Bill 488: North Carolina’s Opportunity to Meaningfully Impact Maternal and Infant Health Outcomes
House Bill 488: North Carolina’s Opportunity to Meaningfully Impact Maternal and Infant Health Outcomes By Tyler C. Fox, BA and Rishika Reddy, BS Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Fox T, Reddy R. House Bill 488: North Carolina’s Opportunity to meaningfully impact maternal and infant health outcomes. HPHR. […]
Edition 45 – Caution Is Required When Clinically Implementing AI Models: What the Covid-19 Pandemic Taught Us About Regulation and Validation
Caution Is Required When Clinically Implementing AI Models: What the COVID-19 Pandemic Taught Us About Regulation and Validation By Keerthi B. Harish and Yindalon Aphinyanaphongs Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Harish K, Aphinyanaphongs Y. Caution is required when clinically implementing ai models: what the COVID-19 pandemic taught […]
Edition 40 – AI to Transform the Drug Approval Process and De-Risk Drug Development
AI to Transform the Drug Approval Process and De-Risk Drug Development By Cherubin Manokaran Facebook Twitter LinkedIn Citation Manokaran C. AI to transform the drug approval process and de-risk drug development. HPHR. 2021;40. 10.54111/0001/NN4 AI to Transform the Drug Approval Process and De-risk Drug Development Abstract The public tends to view high drug prices through […]
